Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Breast Cancer Res Treat. 2014 Sep 19;147(3):661–670. doi: 10.1007/s10549-014-3135-z

Table 1.

Individual characteristics of women with non-metastatic invasive breast cancer (N=3,312) stratified by neighborhood socioeconomic deprivation.

Variable Neighborhood Socioeconomic Deprivation a
P b
Q1 (n=827) Q2 (n=828) Q3 (n=826) Q4 (n=831)
Triple-Negative Subtype <0.001
 Yes 126 (15.2) 132 (15.9) 144 (17.4) 219 (26.4)
 No 701 (84.8) 696 (84.1) 682 (82.6) 612 (73.7)
Age (Years) 0.108
 <45 195 (23.6) 178 (21.5) 146 (17.7) 172 (20.7)
 45–54 269 (32.5) 253 (30.6) 268 (32.5) 286 (34.4)
 55–64 226 (27.3) 256 (30.9) 251 (30.4) 238 (28.6)
 65–74 137 (16.6) 141 (17.0) 161 (19.5) 135 (16.3)
Race <0.001
 White 776 (93.8) 763 (92.2) 677 (82.0) 204 (24.6)
 AA 21 (2.5) 45 (5.4) 131 (15.9) 615 (74.0)
 Others 30 (3.6) 20 (2.4) 18 (2.2) 12 (1.4)
Marital <0.001
 Married/Partnered 623 (75.3) 566 (68.4) 463 (56.1) 277 (33.3)
 Unmarried/Unpartnered 204 (24.7) 262 (31.6) 363 (44.0) 554 (66.7)
Insurance <0.001
 Private/managed care 572 (69.2) 534 (64.5) 464 (56.2) 360 (43.3)
 Medicaid/Medicare/public 203 (24.6) 242 (29.3) 310 (37.5) 418 (50.3)
 Uninsured 52 (6.3) 52 (6.3) 52 (6.3) 53 (6.4)
Stage <0.001
 I 381 (46.1) 377 (45.5) 336 (40.7) 286 (34.4)
 II 334 (40.4) 343 (41.4) 361 (43.7) 403 (48.5)
 III 112 (13.5) 108 (13.0) 129 (15.6) 142 (17.1)
Grade <0.001
 Well differentiated 198 (23.9) 189 (22.8) 204 (24.7) 146 (17.6)
 Moderately 324 (39.2) 310 (37.4) 303 (36.7) 237 (28.5)
 Poorly 305 (36.9) 329 (39.7) 319 (38.6) 448 (53.9)
Comorbidity <0.001
 Mild/no 661 (89.3) 632 (86.5) 622 (85.6) 605 (79.1)
 Moderately 49 (6.6) 59 (8.1) 66 (9.1) 110 (14.4)
 Severe 30 (4.1) 40 (5.5) 39 (5.4) 50 (6.5)
 Missing 87 97 99 66
Hormone therapy <0.001
 Yes 562 (68.8) 526 (64.4) 535 (66.0) 439 (53.3)
 No 255 (31.2) 291 (35.6) 276 (34.0) 384 (46.7)
 Missing 10 11 15 8
Trastuzumab therapy 0.475
 Yes 55 (6.7) 41 (5.0) 44 (5.3) 46 (5.5)
 No 772 (93.4) 787 (95.1) 782 (94.7) 785 (94.5)
Chemotherapy 0.017
 Yes 512 (62.1) 502 (60.9) 501 (61.2) 555 (67.5)
 No 312 (37.9) 322 (39.1) 318 (38.8) 267 (32.5)
 Missing 3 4 7 9
Radiotherapy 0.401
 Yes 549 (66.9) 565 (68.8) 548 (67.0) 533 (64.8)
 No 272 (33.1) 256 (31.2) 270 (33.0) 289 (35.2)
 Missing 6 7 8 9
Surgery 0.001
 Mastectomy 382 (46.5) 375 (45.5) 363 (44.15) 342 (41.3)
 Lumpectomy 432 (52.6) 440 (53.3) 446 (54.1) 457 (55.1)
 None 8 (1.0) 10 (1.2) 15 (1.8) 30 (3.6)
 Missing 5 3 2 2
Alcohol use <0.001
 No or former use 472 (57.7) 501 (61.3) 526 (64.2) 552 (67. 6)
 Current use 346 (42.3) 316 (38.7) 294 (35.9) 265 (32.4)
 Missing 9 11 6 14
Smoking status <0.001
 Non-smoker/former 482 (66.2) 444 (60.0) 432 (57.2) 406 (53.1)
 Current smoker 246 (33.8) 296 (40.0) 323 (42.8) 359 (46.9)
 Missing 99 88 71 66
a

Q1 denotes the least socioeconomically deprived quartile and Q4 denotes the most socioeconomically deprived quartile; there were 242 census tracts in Q1, 230 in Q2, 236 in Q3, and 159 in Q4.

b

Chi-square tests.